Dernières publications

Chiffres clés

130 Publications avec texte intégral

Open Access

55 %

Mots clés

Autoantibody Auto‐antibodies Agalsidase Anti-interleukin-6 AAV Inclusion body myositis Antisynthetase DM Anticorps anti-agalsidase Anti-MDA5 Pharmacology Antiphospholipid syndrome Interferon Anti‐mitochondrial antibodies Idiopathic inflammatory myopathies Inflammation Cancer Biomarkers Antisynthétase Anti-Mi2 IMNM Interstitial lung disease AAV vectors COVID-19 AAV antibody Autoimmunity Lysosomal storage diseases Inflammatory myopathy Immune checkpoint inhibitors Acid-alpha-glucosidase Biomarqueurs Mass cytometry Adeno-associated virus vector Fabry disease Amyotrophic lateral sclerosis Humans Aldosterone Anti-synthetase syndrome Female Anémie hémolytique Autoantibodies Auto-antibodies Analyses multidimensionnelles Muscle Anti-MDA5 autoantibodies Autoimmune diseases IBM Cardio-oncology Deep immune profiling Machine learning Aldostérone Dependovirus/genetics/immunology AAV vector Gene therapy Dermatomyositis Anti-agalsidase antibodies Acute Kidney Injury/epidemiology/etiology Myosites Antisynthetase syndrome B-lymphocyte Adjudication Immunotherapy Myocarditis Skeletal muscle Antibodies Aged Anti‐MDA5 Abnormal movement Cytokines Male Anti-IgE IgG Middle Aged Inborn errors of metabolism Systems biology AAV humoral immunity Acetylcholine receptor antibodies Arthritis Adeno-associated virus Prognosis Myopathy Adult Auto-immunité Amyotrophy Antibody responses Adverse drug reactions Active Sphingosine-1-phosphate Myositis Animals Polymyositis Adeno-associated vector Outcome measures Anti-drug antibodies Biomarker Assisted communication devices B cell homeostasis Myositis and muscle disease Adolescence Idiopathic inflammatory myopathy Anticorps spécifique des myosites